New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 28, 2012
07:07 EDTOMEROmeros price target lowered to $16 from $19 at Burrill
Burrill lowered its price target for Omeros after the company announced that OMS103HP did not meet its primary endpoint in patients undergoing arthroscopic partial meniscectomy surgery. The firm notes that OMS103HP achieved statistically significant reduction of postoperative pain, though, and keeps an Outperform rating on the stock.
News For OMER From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
17:10 EDTOMEROn The Fly: Closing Wrap
Stocks on Wall Street advanced, with a strong move higher from Visa (V) after its earnings report accounting for more than 100 points of the Dow's increase. The Nasdaq, which lagged all day, eventually moved off its lows and closed in positive territory as well. The New York Stock Exchange notified customers of a problem at 1:40 p.m., saying there was a “critical issue” and it was “experiencing issues publishing and receiving trades and quotes.” Ten minutes later, it sent a new alert saying the system was “processing trades and quotes normally.” ECONOMIC EVENTS: In the U.S., GDP grew 3.5% in the third quarter, topping the consensus forecast for 3.1% growth. Initial jobless claims rose 3K to 287K in the week ended October 25, which was narrowly above the 285K consensus estimate. COMPANY NEWS: Shares of credit card networks Visa (V) and MasterCard (MA) are rising after both companies reported stronger than expected results. Visa, which also authorized a new $5B share repurchase program and was upgraded to Outperform from Market Perform at FBR Capital, advanced $21.99, or 10.24%, to $236.65, while MasterCard gained $7.14, or 9.4%, to $83.13... Apple (AAPL) CEO Tim Cook publicly acknowledged in an essay published by Bloomberg Businessweek that he is gay. Cook noted that he feels "if hearing that the CEO of Apple is gay can help someone struggling to come to terms with who he or she is, or bring comfort to anyone who feels alone, or inspire people to insist on their equality, then it’s worth the trade-off with my own privacy." MAJOR MOVERS: Among the notable gainers was Bristol-Myers (BMY), which advanced $4.82, or 8.9%, to $58.98 after the company announced data for a trial of its Opdivo drug in certain lung cancer patients that a doctor involved in the study called "encouraging." Also higher was Omeros (OMER), which rose $4.99, or 43.09%, to $16.57 after the company announced it has received transitional pass-through status for its lead product, Omidria, from the Center for Medicare & Medicaid Services. Among the noteworthy losers was Glu Mobile (GLUU), which fell 92c, or 20.31%, to $3.61 after the game maker reported Q3 EPS that beat consensus but non-GAAP revenue that missed expectations. Also lower were shares of beauty products provider Avon (AVP), which fell 99c, or 9.03%, to $9.97 after its third quarter report. INDEXES: The Dow rose 221.11, or 1.3%, to 17,195.42, the Nasdaq gained 16.91, or 0.37%, to 4,566.14, and the S&P 500 added 12.35, or 0.62%, to 1,994.65.
07:37 EDTOMEROmeros' Omidria granted pass-through reimbursement status from CMS
Subscribe for More Information
October 21, 2014
12:57 EDTOMEROn The Fly: Midday Wrap
Subscribe for More Information
09:15 EDTOMEROn The Fly: Pre-market Movers
UP AFTER EARNINGS: Apple (AAPL), up 3%... Texas Instruments (TXN), up 2.3%... Harley Davidson (HOG), up 7%... Celanese (CE), up 4%... United Technologies (UTX), up 1.4%. ALSO HIGHER: Neonode (NEON), up 20% after signing technology development agreement with global tier-one printer OEM... Illumina (ILMN), up 10%, upgraded at Janney Capital following the company's better than expected Q3 earnings. DOWN AFTER EARNINGS: Coca-Cola (KO), down 5%... Chipotle (CMG), down 4.6%... Verizon (VZ), down 1%. ALSO LOWER: CEL-SCI (CVM), down 15.3% after announcing proposed offering of common stock, warrants... Omeros (OMER), down 12% after suspending Huntington's clinical trial with OMS824... Tesoro Logistics (TLLP), down 2.4% after 20M share secondary priced at $57.47... Rhino Resources (RNO), down 53%, downgraded to Underperform at Raymond James following the reduction in its quarterly cash dividend.
07:10 EDTOMEROmeros suspends its Huntington's clinical trial with OMS824
Subscribe for More Information
October 20, 2014
07:16 EDTOMERAmerican Academy of Ophthalmology to hold annual meeting
AAO Annual Meeting 2014 is being held in Chicago on October 18-21.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use